Urine-Based Biomarkers in the Diagnosis of Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis
Journal of Clinical Medicine · 19.02.2026 · 15 (4) · 1612
DOI: 10.3390/jcm15041612 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 19.02.2026. Verfasst von Hanqing Xiao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Nature Science Foundation of China, Natural Science Foundation of the Science and Technology Innovation Action Plan of Shanghai.
Abstract (Originalsprache)
Background
Upper tract urothelial carcinoma (UTUC) is a rare malignancy with a poor prognosis. Current diagnostic methods such as ureteroscopic biopsy and imaging techniques are invasive, costly, or have low sensitivity. Urine-based biomarkers represent a promising non-invasive alternative.
Objective
To systematically review and meta-analyze the diagnostic accuracy of various urine-based biomarkers for UTUC and provide a head-to-head comparison.
Methods
A comprehensive literature search was conducted in PubMed, Scopus, Embase, Cochrane, and Web of Science from January 2000 to October 2025. Studies meeting PICOS criteria were included. Diagnostic performance metrics including sensitivity (SEN), specificity (SPE), positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), and area under the curve (AUC) were extracted. Data were synthesized using the MIDAS module in StataMP 18.0.
Results
Seventeen studies involving 2734 patients were included. The overall pooled sensitivity was 0.86, specificity 0.94, diagnostic odds ratio 93, and AUC 0.94. DNA methylation assays showed balanced performance (SEN = 0.89, SPE = 0.92), gene mutation assays had the highest specificity (SPE = 0.97), RNA assays had the highest sensitivity (SEN = 0.97) but low specificity (SPE = 0.25). Significant heterogeneity was observed, but no notable publication bias was detected.
Conclusions
Urine-based biomarkers demonstrate high diagnostic performance for UTUC, particularly DNA methylation assays. Future prospective studies are warranted to validate their clinical utility.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
- Department of Urology, Ruijin Hospital Lu Wan Branch, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
- Department of Urology, Sanming First Hospital Affiliated to Fujian Medical University, Sanming 365000, China.
Förderung
- National Nature Science Foundation of China
- Natural Science Foundation of the Science and Technology Innovation Action Plan of Shanghai
Zitieren
APA
Xiao, H., Yi, L., Ma, Z., Dai, K., Liu, Y., Gao, Y., Xu, D., & Huang, H. (2026). Urine-Based Biomarkers in the Diagnosis of Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine, 15(4), 1612. https://doi.org/10.3390/jcm15041612
Vancouver
Xiao H, Yi L, Ma Z, Dai K, Liu Y, Gao Y, et al. Urine-Based Biomarkers in the Diagnosis of Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2026;15(4):1612. doi:10.3390/jcm15041612
BibTeX
@article{Xiao2026,
author = {Xiao, Hanqing and Yi, Liqi and Ma, Zhiyang and Dai, Kaihan and Liu, Yulai and Gao, Yi and Xu, Danfeng and Huang, Hai},
title = {Urine-Based Biomarkers in the Diagnosis of Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {4},
pages = {1612},
doi = {10.3390/jcm15041612}
}
EUVIMED